Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxk1
|
ENSMUSG00000056493.8 | forkhead box K1 |
Foxj1
|
ENSMUSG00000034227.7 | forkhead box J1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_116332237_116332388 | Foxj1 | 3087 | 0.133481 | -0.48 | 2.0e-04 | Click! |
chr11_116332505_116332892 | Foxj1 | 2701 | 0.145067 | -0.44 | 7.6e-04 | Click! |
chr11_116335104_116335349 | Foxj1 | 173 | 0.902321 | -0.36 | 6.8e-03 | Click! |
chr11_116335367_116335561 | Foxj1 | 65 | 0.947470 | -0.30 | 2.8e-02 | Click! |
chr11_116333780_116333931 | Foxj1 | 1544 | 0.232969 | 0.23 | 9.8e-02 | Click! |
chr5_142418000_142418174 | Foxk1 | 16587 | 0.198154 | 0.67 | 1.8e-08 | Click! |
chr5_142416088_142416498 | Foxk1 | 14793 | 0.203830 | 0.66 | 3.9e-08 | Click! |
chr5_142426663_142426814 | Foxk1 | 25238 | 0.170002 | 0.65 | 8.8e-08 | Click! |
chr5_142403786_142404079 | Foxk1 | 2432 | 0.337444 | 0.62 | 4.6e-07 | Click! |
chr5_142402125_142402505 | Foxk1 | 815 | 0.688059 | 0.59 | 2.3e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_50210669_50211262 | 25.70 |
Nell1 |
NEL-like 1 |
112655 |
0.07 |
chr9_67235542_67235843 | 24.43 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr14_121355790_121356113 | 22.85 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr7_143769581_143769748 | 22.59 |
Mrgprg |
MAS-related GPR, member G |
2671 |
0.15 |
chr17_6804856_6805157 | 21.64 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
3503 |
0.19 |
chr11_57960034_57960300 | 21.24 |
Gm12245 |
predicted gene 12245 |
11082 |
0.15 |
chr6_5287440_5287910 | 21.08 |
Pon2 |
paraoxonase 2 |
1393 |
0.4 |
chr5_142920434_142920596 | 21.08 |
Actb |
actin, beta |
13761 |
0.14 |
chr5_137349031_137350198 | 20.67 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr7_98048253_98048538 | 20.20 |
Myo7a |
myosin VIIA |
16807 |
0.21 |
chr14_41007337_41007980 | 19.07 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr9_50692728_50692943 | 19.06 |
Dixdc1 |
DIX domain containing 1 |
964 |
0.45 |
chr2_178471923_178472101 | 18.90 |
Cdh26 |
cadherin-like 26 |
11382 |
0.22 |
chr1_166002288_166003185 | 18.28 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr19_42985649_42985808 | 17.94 |
Gm22135 |
predicted gene, 22135 |
175174 |
0.03 |
chr5_139681780_139682442 | 17.88 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr2_6331309_6331868 | 17.87 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr16_4559726_4560765 | 17.72 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr9_98313593_98313876 | 17.70 |
Gm28530 |
predicted gene 28530 |
12084 |
0.2 |
chr4_59292306_59292644 | 17.64 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr5_139734496_139734696 | 17.64 |
Micall2 |
MICAL-like 2 |
1740 |
0.28 |
chr10_111696233_111696479 | 17.41 |
Gm30624 |
predicted gene, 30624 |
28828 |
0.14 |
chr8_23053611_23053959 | 17.40 |
Ank1 |
ankyrin 1, erythroid |
4474 |
0.2 |
chr7_127931896_127932670 | 17.31 |
Prss8 |
protease, serine 8 (prostasin) |
2179 |
0.12 |
chr13_23697544_23698095 | 17.29 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr12_118186558_118187081 | 17.23 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
12224 |
0.25 |
chr10_30755475_30755626 | 17.17 |
Gm48335 |
predicted gene, 48335 |
11588 |
0.14 |
chr3_150193122_150193524 | 17.17 |
Rpsa-ps10 |
ribosomal protein SA, pseudogene 10 |
119781 |
0.07 |
chr12_79674954_79675872 | 17.02 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr8_83785101_83785408 | 17.01 |
Gm45778 |
predicted gene 45778 |
35750 |
0.1 |
chr11_76884538_76884711 | 17.01 |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
17535 |
0.16 |
chr1_185472844_185473015 | 16.87 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
14365 |
0.12 |
chr12_45080896_45081047 | 16.84 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
6262 |
0.21 |
chr1_184781740_184782518 | 16.72 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr1_184060400_184060753 | 16.64 |
Dusp10 |
dual specificity phosphatase 10 |
26195 |
0.19 |
chr13_34299446_34299869 | 16.57 |
Gm47086 |
predicted gene, 47086 |
19151 |
0.18 |
chr8_94354649_94354841 | 16.19 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr5_121469775_121469964 | 16.12 |
Gm15546 |
predicted gene 15546 |
2519 |
0.14 |
chr5_97834809_97835101 | 15.95 |
Antxr2 |
anthrax toxin receptor 2 |
161140 |
0.03 |
chr6_84640633_84641008 | 15.91 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr1_187155725_187155876 | 15.72 |
Spata17 |
spermatogenesis associated 17 |
12703 |
0.15 |
chr10_80858382_80858558 | 15.60 |
Sppl2b |
signal peptide peptidase like 2B |
1349 |
0.2 |
chr16_76319178_76320114 | 15.38 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr14_75837044_75838069 | 15.36 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr5_146307529_146307719 | 15.31 |
Cdk8 |
cyclin-dependent kinase 8 |
11259 |
0.17 |
chr4_139387042_139387343 | 15.30 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6523 |
0.12 |
chr11_69062573_69063351 | 15.23 |
9330160F10Rik |
RIKEN cDNA 9330160F10 gene |
2479 |
0.1 |
chr2_133141464_133141642 | 15.22 |
Gm14094 |
predicted gene 14094 |
58058 |
0.12 |
chr9_61370339_61371660 | 15.07 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr7_35134765_35134932 | 15.05 |
Gm35665 |
predicted gene, 35665 |
6601 |
0.11 |
chr11_85786468_85786638 | 14.88 |
Gm23473 |
predicted gene, 23473 |
7741 |
0.12 |
chr2_164438281_164438523 | 14.51 |
Sdc4 |
syndecan 4 |
4784 |
0.1 |
chr5_123223029_123223358 | 14.50 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr2_78718744_78718973 | 14.48 |
Gm14463 |
predicted gene 14463 |
61429 |
0.13 |
chr7_103826228_103826489 | 14.46 |
Hbb-bs |
hemoglobin, beta adult s chain |
1367 |
0.17 |
chr11_109488104_109488259 | 14.31 |
Arsg |
arylsulfatase G |
2575 |
0.19 |
chr9_78105526_78105687 | 14.29 |
Fbxo9 |
f-box protein 9 |
2981 |
0.16 |
chr1_193159259_193159410 | 14.21 |
Irf6 |
interferon regulatory factor 6 |
2665 |
0.17 |
chr6_99012035_99012219 | 14.17 |
Foxp1 |
forkhead box P1 |
8447 |
0.28 |
chr2_27982205_27982376 | 14.14 |
Col5a1 |
collagen, type V, alpha 1 |
35151 |
0.16 |
chr1_157525893_157526398 | 13.91 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
2 |
0.97 |
chr10_96686112_96686478 | 13.91 |
Gm48507 |
predicted gene, 48507 |
25512 |
0.18 |
chr10_93538875_93539026 | 13.87 |
Amdhd1 |
amidohydrolase domain containing 1 |
1083 |
0.37 |
chr4_87805858_87806167 | 13.82 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
282 |
0.95 |
chr2_29677911_29678077 | 13.81 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr6_5156932_5157313 | 13.75 |
Pon1 |
paraoxonase 1 |
36641 |
0.14 |
chr17_14697154_14697340 | 13.64 |
Thbs2 |
thrombospondin 2 |
3012 |
0.28 |
chr1_182399333_182399493 | 13.61 |
Gm5706 |
predicted gene 5706 |
5878 |
0.15 |
chr3_60785598_60785915 | 13.54 |
Gm38326 |
predicted gene, 38326 |
2605 |
0.27 |
chr8_121127592_121127785 | 13.54 |
Foxl1 |
forkhead box L1 |
252 |
0.88 |
chr6_143067791_143067965 | 13.47 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
793 |
0.63 |
chr4_41387869_41388043 | 13.46 |
Ubap1 |
ubiquitin-associated protein 1 |
16231 |
0.12 |
chr7_76651216_76651367 | 13.42 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
40226 |
0.19 |
chr5_146679205_146679645 | 13.35 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
27197 |
0.15 |
chr9_107971568_107971739 | 13.34 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3852 |
0.07 |
chr2_163586914_163587109 | 13.33 |
Ttpal |
tocopherol (alpha) transfer protein-like |
15303 |
0.13 |
chr11_12291035_12291789 | 13.30 |
Gm12002 |
predicted gene 12002 |
23102 |
0.24 |
chr10_115817172_115817352 | 13.25 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr5_51039988_51040153 | 13.24 |
Gm40319 |
predicted gene, 40319 |
12311 |
0.29 |
chr3_157636891_157637254 | 13.24 |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
70172 |
0.09 |
chr11_11841342_11841508 | 13.21 |
Ddc |
dopa decarboxylase |
5145 |
0.2 |
chr11_49088722_49088986 | 13.12 |
Gm12188 |
predicted gene 12188 |
311 |
0.62 |
chr14_32168431_32168589 | 13.11 |
Ncoa4 |
nuclear receptor coactivator 4 |
2235 |
0.18 |
chr16_72734272_72734567 | 13.07 |
Robo1 |
roundabout guidance receptor 1 |
71215 |
0.14 |
chr2_145233828_145234346 | 13.06 |
Slc24a3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
8524 |
0.29 |
chr1_170479226_170479433 | 13.04 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
24415 |
0.21 |
chr12_40888004_40888165 | 12.99 |
Gm7239 |
predicted gene 7239 |
3470 |
0.2 |
chr7_123097743_123098471 | 12.93 |
Tnrc6a |
trinucleotide repeat containing 6a |
25778 |
0.17 |
chr15_84707072_84707245 | 12.84 |
Arhgap8 |
Rho GTPase activating protein 8 |
12894 |
0.16 |
chr7_75611639_75612062 | 12.82 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr13_52831701_52831898 | 12.82 |
BB123696 |
expressed sequence BB123696 |
74594 |
0.1 |
chr2_60940262_60940686 | 12.75 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr11_20636524_20636686 | 12.74 |
Sertad2 |
SERTA domain containing 2 |
4626 |
0.25 |
chr12_80114135_80114615 | 12.69 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
1362 |
0.27 |
chr9_116847869_116848051 | 12.68 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
25141 |
0.27 |
chr11_8503775_8504139 | 12.65 |
Tns3 |
tensin 3 |
35282 |
0.23 |
chr11_78074361_78074827 | 12.64 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr11_48855844_48857180 | 12.48 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr5_115977292_115977636 | 12.46 |
Cit |
citron |
9439 |
0.15 |
chr10_121429894_121430401 | 12.44 |
Gm18730 |
predicted gene, 18730 |
29434 |
0.1 |
chr11_35951474_35951674 | 12.40 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
28953 |
0.19 |
chr5_107046596_107046884 | 12.39 |
Gm33474 |
predicted gene, 33474 |
2096 |
0.34 |
chr13_112746031_112746187 | 12.39 |
Slc38a9 |
solute carrier family 38, member 9 |
10499 |
0.15 |
chr6_108638896_108639047 | 12.39 |
Gm17055 |
predicted gene 17055 |
17946 |
0.14 |
chr10_115816613_115816915 | 12.38 |
Tspan8 |
tetraspanin 8 |
68 |
0.98 |
chr17_86313458_86313775 | 12.36 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
26438 |
0.23 |
chr10_54042474_54042667 | 12.32 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr10_37231291_37231825 | 12.31 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
32190 |
0.19 |
chr2_84850740_84851058 | 12.27 |
Slc43a1 |
solute carrier family 43, member 1 |
10274 |
0.11 |
chr1_94581777_94581957 | 12.26 |
Gm23389 |
predicted gene, 23389 |
33837 |
0.23 |
chr1_164260228_164260484 | 12.26 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
1997 |
0.27 |
chr2_73312496_73313091 | 12.22 |
Cir1 |
corepressor interacting with RBPJ, 1 |
92 |
0.53 |
chr7_120865040_120865504 | 12.19 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr11_77983926_77984968 | 12.14 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr10_116205591_116205964 | 12.07 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
9381 |
0.23 |
chr19_53329198_53330470 | 12.05 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr7_49195732_49195929 | 12.04 |
Gm37613 |
predicted gene, 37613 |
289 |
0.92 |
chr1_139075991_139076142 | 12.04 |
Gm43544 |
predicted gene 43544 |
5853 |
0.14 |
chr2_180234460_180234650 | 12.02 |
Lama5 |
laminin, alpha 5 |
8696 |
0.12 |
chr14_30363569_30363894 | 12.01 |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
10204 |
0.15 |
chr2_127375314_127375491 | 11.97 |
Adra2b |
adrenergic receptor, alpha 2b |
12116 |
0.14 |
chr12_69367557_69367877 | 11.96 |
Gm18113 |
predicted gene, 18113 |
2306 |
0.15 |
chr6_90650730_90650881 | 11.94 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
11483 |
0.14 |
chr1_40230393_40230707 | 11.93 |
Il1r1 |
interleukin 1 receptor, type I |
5470 |
0.21 |
chr6_125575147_125575338 | 11.93 |
Vwf |
Von Willebrand factor |
8991 |
0.21 |
chr5_123201506_123201803 | 11.92 |
Gm43409 |
predicted gene 43409 |
10066 |
0.1 |
chr12_84400565_84400716 | 11.87 |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
245 |
0.87 |
chr10_19631711_19631874 | 11.87 |
Il22ra2 |
interleukin 22 receptor, alpha 2 |
9794 |
0.17 |
chr3_69812507_69812796 | 11.85 |
Sptssb |
serine palmitoyltransferase, small subunit B |
47271 |
0.13 |
chr8_33981022_33981341 | 11.85 |
Gm39157 |
predicted gene, 39157 |
4733 |
0.18 |
chr10_8233633_8233789 | 11.78 |
Gm30906 |
predicted gene, 30906 |
57580 |
0.14 |
chr6_134664499_134665111 | 11.77 |
Borcs5 |
BLOC-1 related complex subunit 5 |
23550 |
0.12 |
chr7_103825678_103825891 | 11.76 |
Hbb-bs |
hemoglobin, beta adult s chain |
1941 |
0.12 |
chr19_27316918_27317237 | 11.69 |
Kcnv2 |
potassium channel, subfamily V, member 2 |
5511 |
0.2 |
chr12_111896884_111897036 | 11.66 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
10659 |
0.12 |
chr6_34412159_34412311 | 11.66 |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
99 |
0.95 |
chr8_82939765_82940357 | 11.63 |
Gm18212 |
predicted gene, 18212 |
12451 |
0.24 |
chr13_63564531_63566515 | 11.63 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr14_48476338_48476652 | 11.61 |
Tmem260 |
transmembrane protein 260 |
3058 |
0.21 |
chr7_37660813_37661200 | 11.56 |
Gm44883 |
predicted gene 44883 |
1632 |
0.41 |
chr7_16815354_16816404 | 11.53 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr10_51631600_51631902 | 11.53 |
Gprc6a |
G protein-coupled receptor, family C, group 6, member A |
290 |
0.87 |
chr7_3073202_3073372 | 11.47 |
Gm3104 |
predicted gene 3104 |
12714 |
0.1 |
chr13_46875476_46875736 | 11.47 |
Gm48250 |
predicted gene, 48250 |
5421 |
0.17 |
chr10_128335655_128335955 | 11.47 |
Cs |
citrate synthase |
1929 |
0.13 |
chr12_116111150_116111301 | 11.43 |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
26122 |
0.1 |
chr10_68090596_68090764 | 11.36 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
45946 |
0.13 |
chr10_13210007_13210663 | 11.34 |
Gm47402 |
predicted gene, 47402 |
5109 |
0.21 |
chr5_143574531_143574739 | 11.33 |
Fam220a |
family with sequence similarity 220, member A |
25595 |
0.13 |
chr7_126975552_126976438 | 11.31 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr9_90235030_90235570 | 11.27 |
Gm16200 |
predicted gene 16200 |
13675 |
0.16 |
chr17_47439741_47439945 | 11.26 |
1700001C19Rik |
RIKEN cDNA 1700001C19 gene |
2467 |
0.17 |
chr18_62180293_62180673 | 11.26 |
Gm9949 |
predicted gene 9949 |
357 |
0.62 |
chr3_34747544_34747782 | 11.25 |
Gm38509 |
predicted gene, 38509 |
24412 |
0.14 |
chr9_71163197_71163362 | 11.22 |
Aqp9 |
aquaporin 9 |
10 |
0.91 |
chr15_56623570_56623885 | 11.20 |
Has2os |
hyaluronan synthase 2, opposite strand |
66217 |
0.12 |
chr5_103499408_103499559 | 11.18 |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
30083 |
0.16 |
chr5_51829102_51829379 | 11.18 |
Gm43606 |
predicted gene 43606 |
29535 |
0.17 |
chr18_56978164_56978384 | 11.17 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2906 |
0.3 |
chr10_21686289_21686471 | 11.14 |
Gm5420 |
predicted gene 5420 |
31 |
0.98 |
chr2_156439817_156439982 | 11.13 |
Gm14225 |
predicted gene 14225 |
7709 |
0.1 |
chr1_91490299_91490493 | 11.08 |
Gm19085 |
predicted gene, 19085 |
387 |
0.77 |
chr2_158153650_158154051 | 11.08 |
Tgm2 |
transglutaminase 2, C polypeptide |
7414 |
0.16 |
chr2_170270298_170270480 | 11.07 |
Gm14270 |
predicted gene 14270 |
14646 |
0.23 |
chr12_104748567_104748718 | 11.07 |
Dicer1 |
dicer 1, ribonuclease type III |
3310 |
0.27 |
chr1_80716075_80716226 | 11.06 |
Dock10 |
dedicator of cytokinesis 10 |
6654 |
0.19 |
chr5_137671429_137671814 | 11.00 |
Agfg2 |
ArfGAP with FG repeats 2 |
7305 |
0.08 |
chr11_32293637_32293804 | 10.98 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
2769 |
0.15 |
chr17_30010480_30010631 | 10.98 |
Zfand3 |
zinc finger, AN1-type domain 3 |
2758 |
0.19 |
chr13_107101149_107101349 | 10.97 |
Gm31452 |
predicted gene, 31452 |
37554 |
0.14 |
chr4_128669269_128669559 | 10.96 |
Phc2 |
polyhomeotic 2 |
14676 |
0.17 |
chr5_147894219_147894411 | 10.95 |
Slc46a3 |
solute carrier family 46, member 3 |
500 |
0.77 |
chr1_46852832_46854284 | 10.95 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
488 |
0.78 |
chr17_47914586_47915244 | 10.90 |
Gm15556 |
predicted gene 15556 |
7463 |
0.14 |
chr3_121346684_121346842 | 10.90 |
Gm5711 |
predicted gene 5711 |
33916 |
0.12 |
chr17_47909349_47909983 | 10.90 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr11_58021710_58021982 | 10.86 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
12782 |
0.15 |
chr8_109584965_109585123 | 10.80 |
Hp |
haptoglobin |
5872 |
0.14 |
chr1_168012047_168012363 | 10.78 |
Gm20711 |
predicted gene 20711 |
8066 |
0.32 |
chr1_183344775_183345109 | 10.76 |
Mia3 |
melanoma inhibitory activity 3 |
354 |
0.83 |
chr16_10349978_10350197 | 10.73 |
Gm1600 |
predicted gene 1600 |
2496 |
0.24 |
chr10_100073268_100073419 | 10.71 |
Kitl |
kit ligand |
14713 |
0.18 |
chr8_120486990_120488549 | 10.71 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr13_111957244_111957406 | 10.70 |
Gm15322 |
predicted gene 15322 |
34141 |
0.14 |
chr11_105905566_105905858 | 10.70 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
3729 |
0.17 |
chr11_16559834_16559985 | 10.70 |
Akt2-ps |
thymoma viral proto-oncogene 2, pseudogene |
45376 |
0.13 |
chr18_84885392_84885727 | 10.68 |
Cyb5a |
cytochrome b5 type A (microsomal) |
7958 |
0.17 |
chr10_94574788_94575101 | 10.67 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr12_80130626_80131086 | 10.64 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
1740 |
0.26 |
chr12_103393592_103393793 | 10.64 |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
1038 |
0.34 |
chr2_167958906_167959081 | 10.63 |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
7945 |
0.17 |
chr2_164733298_164733449 | 10.61 |
Wfdc3 |
WAP four-disulfide core domain 3 |
9939 |
0.07 |
chr10_77242950_77243154 | 10.61 |
Pofut2 |
protein O-fucosyltransferase 2 |
16166 |
0.17 |
chr10_98504531_98504809 | 10.61 |
Gm37631 |
predicted gene, 37631 |
17797 |
0.23 |
chr1_9787554_9787806 | 10.60 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
3902 |
0.16 |
chr10_117106272_117106596 | 10.59 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24412 |
0.12 |
chr3_94783418_94783615 | 10.56 |
Cgn |
cingulin |
2935 |
0.17 |
chr4_139335168_139335391 | 10.56 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1901 |
0.15 |
chr1_9435374_9435532 | 10.55 |
Gm18299 |
predicted gene, 18299 |
4923 |
0.16 |
chr8_99650698_99651059 | 10.53 |
Gm8688 |
predicted gene 8688 |
13141 |
0.29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 8.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
8.1 | 24.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
5.9 | 17.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.6 | 16.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
5.3 | 26.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
5.2 | 20.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
5.2 | 15.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
5.2 | 25.9 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
5.0 | 14.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
4.9 | 14.7 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
4.8 | 14.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
4.7 | 14.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.2 | 12.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.1 | 12.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
4.0 | 12.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.9 | 11.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.8 | 11.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
3.8 | 26.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.8 | 18.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.7 | 21.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.6 | 7.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.5 | 3.5 | GO:0002688 | regulation of leukocyte chemotaxis(GO:0002688) |
3.5 | 14.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
3.5 | 17.4 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
3.4 | 13.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
3.4 | 10.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.3 | 13.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.2 | 13.0 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
3.2 | 6.5 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
3.2 | 12.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
3.1 | 15.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.1 | 9.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
3.0 | 3.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.0 | 12.0 | GO:0009597 | detection of virus(GO:0009597) |
3.0 | 11.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.9 | 8.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.8 | 11.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.8 | 8.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.8 | 8.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.8 | 8.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
2.8 | 2.8 | GO:0061323 | cell proliferation involved in heart morphogenesis(GO:0061323) |
2.7 | 8.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.7 | 8.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.7 | 8.1 | GO:0008050 | female courtship behavior(GO:0008050) |
2.7 | 10.7 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
2.7 | 8.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.6 | 18.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.6 | 7.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
2.6 | 7.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.5 | 12.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.5 | 7.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.5 | 10.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.5 | 7.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.5 | 7.4 | GO:0008228 | opsonization(GO:0008228) |
2.4 | 7.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.4 | 7.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.4 | 12.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.4 | 9.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.4 | 9.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.4 | 7.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.4 | 4.7 | GO:0032439 | endosome localization(GO:0032439) |
2.4 | 9.4 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.3 | 4.7 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.3 | 9.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.3 | 9.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.3 | 2.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.2 | 4.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 6.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.2 | 6.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.2 | 8.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.2 | 2.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.2 | 8.6 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
2.2 | 17.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.1 | 6.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
2.1 | 2.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
2.1 | 6.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.1 | 4.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.1 | 6.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.1 | 6.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
2.1 | 8.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.1 | 6.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.0 | 26.6 | GO:0010226 | response to lithium ion(GO:0010226) |
2.0 | 6.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.0 | 2.0 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.0 | 2.0 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.0 | 4.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
2.0 | 6.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.0 | 2.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.0 | 4.0 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.0 | 8.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.0 | 7.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
2.0 | 2.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
2.0 | 5.9 | GO:1902065 | response to L-glutamate(GO:1902065) |
2.0 | 5.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.0 | 5.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.9 | 9.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.9 | 5.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.9 | 3.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.9 | 13.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.9 | 1.9 | GO:0070384 | Harderian gland development(GO:0070384) |
1.9 | 5.7 | GO:0015888 | thiamine transport(GO:0015888) |
1.9 | 13.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.9 | 5.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.9 | 3.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.9 | 7.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.9 | 7.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.9 | 1.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.8 | 3.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 7.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.8 | 3.7 | GO:0001705 | ectoderm formation(GO:0001705) |
1.8 | 7.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.8 | 1.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.8 | 14.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.8 | 5.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.8 | 1.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.8 | 7.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
1.8 | 5.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.8 | 3.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.8 | 12.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.8 | 7.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.8 | 14.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.8 | 8.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.8 | 5.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
1.8 | 1.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.7 | 12.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.7 | 22.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.7 | 8.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.7 | 3.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 5.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.7 | 5.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.7 | 3.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.7 | 6.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.7 | 10.3 | GO:0006477 | protein sulfation(GO:0006477) |
1.7 | 5.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.7 | 6.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.7 | 10.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.7 | 5.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.7 | 20.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.7 | 5.0 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.7 | 13.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.7 | 5.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.7 | 11.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.7 | 8.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.6 | 6.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 4.9 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.6 | 1.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.6 | 8.2 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.6 | 4.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.6 | 4.9 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.6 | 4.9 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.6 | 1.6 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.6 | 4.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.6 | 9.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 8.1 | GO:0015825 | L-serine transport(GO:0015825) |
1.6 | 3.2 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
1.6 | 6.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.6 | 25.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.6 | 1.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.6 | 4.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.6 | 4.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.6 | 3.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.6 | 7.9 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.6 | 7.9 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.6 | 36.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.6 | 42.5 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.6 | 3.1 | GO:0035973 | aggrephagy(GO:0035973) |
1.6 | 9.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.6 | 6.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.6 | 6.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.6 | 10.9 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.6 | 6.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.6 | 4.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.5 | 4.6 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
1.5 | 7.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.5 | 3.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.5 | 7.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.5 | 4.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.5 | 7.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.5 | 6.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.5 | 12.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.5 | 6.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.5 | 3.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.5 | 3.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.5 | 3.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.5 | 3.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.5 | 3.0 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.5 | 4.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.5 | 5.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.5 | 2.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.5 | 4.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.5 | 10.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.5 | 2.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.5 | 1.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.5 | 11.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.5 | 5.8 | GO:0034214 | protein hexamerization(GO:0034214) |
1.5 | 5.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.5 | 5.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.4 | 1.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.4 | 4.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.4 | 1.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.4 | 5.8 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 2.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.4 | 4.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.4 | 10.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.4 | 1.4 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.4 | 4.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.4 | 10.0 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 7.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.4 | 7.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.4 | 5.6 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.4 | 7.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.4 | 14.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.4 | 1.4 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.4 | 11.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.4 | 1.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.4 | 5.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.4 | 11.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.4 | 2.8 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.4 | 8.3 | GO:0060242 | contact inhibition(GO:0060242) |
1.4 | 9.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.4 | 9.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.4 | 5.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.4 | 4.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.4 | 4.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.4 | 2.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.4 | 5.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.4 | 1.4 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.4 | 15.0 | GO:0043248 | proteasome assembly(GO:0043248) |
1.4 | 4.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.4 | 12.3 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.4 | 4.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.4 | 4.1 | GO:0003383 | apical constriction(GO:0003383) |
1.4 | 10.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.4 | 2.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.4 | 9.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.4 | 6.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.4 | 4.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.3 | 10.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.3 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.3 | 5.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.3 | 4.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 4.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.3 | 2.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.3 | 2.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.3 | 15.9 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 1.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.3 | 3.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 9.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.3 | 2.6 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
1.3 | 1.3 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.3 | 2.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.3 | 5.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.3 | 11.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
1.3 | 2.6 | GO:0071281 | cellular response to iron ion(GO:0071281) |
1.3 | 6.4 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.3 | 9.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.3 | 1.3 | GO:0015791 | polyol transport(GO:0015791) |
1.3 | 3.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.3 | 1.3 | GO:0003166 | bundle of His development(GO:0003166) |
1.3 | 3.8 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
1.3 | 1.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.3 | 1.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.3 | 1.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.3 | 3.8 | GO:0072718 | response to cisplatin(GO:0072718) |
1.3 | 3.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.3 | 1.3 | GO:0034204 | lipid translocation(GO:0034204) |
1.3 | 2.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.2 | 5.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.2 | 8.7 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
1.2 | 5.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.2 | 3.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.2 | 2.5 | GO:0070254 | mucus secretion(GO:0070254) |
1.2 | 4.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.2 | 2.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.2 | 3.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 3.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.2 | 1.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.2 | 2.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.2 | 2.4 | GO:0050904 | diapedesis(GO:0050904) |
1.2 | 9.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.2 | 3.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.2 | 2.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.2 | 4.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.2 | 1.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.2 | 5.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.2 | 8.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.2 | 1.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.2 | 1.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.2 | 3.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.2 | 7.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.2 | 4.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.2 | 2.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.2 | 4.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.2 | 8.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.2 | 2.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.2 | 2.3 | GO:0051029 | rRNA transport(GO:0051029) |
1.2 | 1.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.2 | 18.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.2 | 1.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.1 | 4.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.1 | 3.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.1 | 2.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.1 | 11.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.1 | 4.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.1 | 5.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.1 | 7.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.1 | 10.2 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 7.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.1 | 6.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.1 | 23.6 | GO:0006301 | postreplication repair(GO:0006301) |
1.1 | 2.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.1 | 2.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.1 | 3.4 | GO:0015886 | heme transport(GO:0015886) |
1.1 | 3.4 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 4.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 3.3 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
1.1 | 11.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.1 | 5.6 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.1 | 4.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.1 | 4.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 6.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.1 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.1 | 2.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.1 | 3.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 6.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.1 | 8.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.1 | 3.2 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.1 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 1.1 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) corticotropin hormone secreting cell differentiation(GO:0060128) cell proliferation involved in mesonephros development(GO:0061209) |
1.1 | 7.5 | GO:0042168 | heme metabolic process(GO:0042168) |
1.1 | 4.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.1 | 1.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.1 | 2.1 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
1.1 | 5.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.1 | 3.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
1.1 | 1.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.1 | 13.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 1.1 | GO:0061511 | centriole elongation(GO:0061511) |
1.1 | 3.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.1 | 3.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.1 | 5.3 | GO:0009249 | protein lipoylation(GO:0009249) |
1.1 | 7.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 4.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.1 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.1 | 5.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.1 | 1.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.1 | 4.2 | GO:0019695 | choline metabolic process(GO:0019695) |
1.1 | 6.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.0 | 2.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.0 | 3.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.0 | 3.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.0 | 13.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
1.0 | 3.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
1.0 | 3.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.0 | 12.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 6.3 | GO:0010543 | regulation of platelet activation(GO:0010543) |
1.0 | 27.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.0 | 2.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.0 | 6.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.0 | 4.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.0 | 3.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.0 | 17.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.0 | 3.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.0 | 1.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.0 | 7.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 2.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.0 | 4.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
1.0 | 4.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.0 | 6.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.0 | 1.0 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
1.0 | 4.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 1.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.0 | 2.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 2.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.0 | 2.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.0 | 1.0 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.0 | 1.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.0 | 8.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.0 | 1.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
1.0 | 4.0 | GO:0042737 | drug catabolic process(GO:0042737) |
1.0 | 3.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.0 | 3.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.0 | 3.0 | GO:0015819 | lysine transport(GO:0015819) |
1.0 | 1.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.0 | 1.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.0 | 2.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
1.0 | 4.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.0 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
1.0 | 2.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.0 | 4.9 | GO:0018904 | ether metabolic process(GO:0018904) |
1.0 | 3.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 4.9 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.0 | 4.9 | GO:0009642 | response to light intensity(GO:0009642) |
1.0 | 2.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 2.9 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.0 | 1.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 3.9 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 1.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 2.9 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.0 | 17.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 5.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 2.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 4.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.0 | 1.9 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.0 | 2.9 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
1.0 | 4.8 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.0 | 1.9 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
1.0 | 2.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 4.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.9 | 2.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.9 | 1.9 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.9 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.9 | 1.9 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 1.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.9 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.9 | 0.9 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.9 | 0.9 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.9 | 1.9 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.9 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 1.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 5.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 3.7 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.9 | 11.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.9 | 4.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 0.9 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.9 | 0.9 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.9 | 2.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.9 | 1.9 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.9 | 2.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.9 | 2.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.9 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 0.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.9 | 1.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 2.8 | GO:0010878 | cholesterol storage(GO:0010878) |
0.9 | 2.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.9 | 4.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.9 | 10.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.9 | 7.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 2.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.9 | 2.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.9 | 2.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.9 | 3.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.9 | 4.5 | GO:0015871 | choline transport(GO:0015871) |
0.9 | 2.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 1.8 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.9 | 2.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 2.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.9 | 7.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 0.9 | GO:0042368 | vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) |
0.9 | 3.5 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.9 | 4.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.9 | 1.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.9 | 3.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.9 | 2.6 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.9 | 0.9 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.9 | 2.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 3.5 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.9 | 2.6 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.9 | 7.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.9 | 9.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 6.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 0.9 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.9 | 0.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.9 | 4.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.9 | 1.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.9 | 7.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.9 | 6.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.9 | 0.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.9 | 8.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.9 | 7.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.9 | 3.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.8 | 7.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 5.1 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.8 | 0.8 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.8 | 1.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.8 | 0.8 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.8 | 3.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.8 | 2.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 3.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.8 | 2.5 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.8 | 0.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.8 | 2.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 3.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 3.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 3.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.8 | 1.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.8 | 0.8 | GO:0031000 | response to caffeine(GO:0031000) |
0.8 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 0.8 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.8 | 0.8 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.8 | 1.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 2.5 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.8 | 3.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.8 | 2.5 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.8 | 4.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.8 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 2.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.8 | 4.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.8 | 1.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.8 | 3.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.8 | 3.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.8 | 12.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 8.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.8 | 10.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.8 | 2.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.8 | 17.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.8 | 0.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.8 | 1.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 2.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.8 | 5.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.8 | 5.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 3.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.8 | 3.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.8 | 4.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.8 | 1.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.8 | 0.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.8 | 4.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.8 | 4.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 11.8 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.8 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.8 | 3.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.8 | 8.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.8 | 2.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 3.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.8 | 1.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 0.8 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.8 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.8 | 2.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 11.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 2.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.8 | 4.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.8 | 2.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.8 | 3.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 3.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 6.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.8 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 2.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 1.5 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 0.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.8 | 5.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.8 | 3.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.8 | 3.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.8 | 1.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.8 | 4.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.8 | 2.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 3.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 2.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.8 | 22.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.8 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 7.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 2.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.8 | 2.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.8 | 1.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 1.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 3.8 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.8 | 1.5 | GO:0090148 | membrane fission(GO:0090148) |
0.8 | 9.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.8 | 1.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.8 | 1.5 | GO:0044838 | cell quiescence(GO:0044838) |
0.8 | 2.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.8 | 9.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.7 | 0.7 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.7 | 2.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.7 | 1.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.7 | 3.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.7 | 1.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 3.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 0.7 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.7 | 5.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.7 | 5.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 1.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 14.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 1.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 3.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.7 | 2.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 8.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.7 | 6.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 2.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.7 | 5.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.7 | 9.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.7 | 3.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 7.9 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.7 | 2.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 2.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 4.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 1.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.7 | 2.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 0.7 | GO:0031929 | TOR signaling(GO:0031929) |
0.7 | 1.4 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.7 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 6.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.7 | 2.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 0.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.7 | 0.7 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.7 | 0.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 2.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 4.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 2.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 0.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.7 | 6.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.7 | 4.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.7 | 1.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.7 | 3.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.7 | 0.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.7 | 13.3 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 1.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.7 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.7 | 3.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 0.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 0.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.7 | 2.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.7 | 9.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 2.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.7 | 2.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.7 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 8.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 8.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 10.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.7 | 0.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.7 | 4.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.7 | 8.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 2.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.7 | 2.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 1.4 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.7 | 0.7 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.7 | 3.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.7 | 7.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.7 | 2.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.7 | 3.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 2.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.7 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.7 | 5.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.7 | 5.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.7 | 1.4 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.7 | 10.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.7 | 4.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.7 | 0.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 1.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 0.7 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.7 | 1.3 | GO:0051299 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
0.7 | 10.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.7 | 0.7 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.7 | 1.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 5.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.7 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.7 | 2.0 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.7 | 2.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.7 | 2.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.7 | 3.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.7 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 4.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.7 | 3.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.7 | 12.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.7 | 0.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.7 | 2.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 6.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.7 | 2.0 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 1.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 2.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 1.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.7 | 3.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.7 | 5.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.7 | 2.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 7.1 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 0.6 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.6 | 7.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 0.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 2.6 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.6 | 1.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 1.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.6 | 0.6 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.6 | 2.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 5.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 2.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 3.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 7.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 3.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 1.9 | GO:0002591 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.6 | 3.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.6 | 1.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 6.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.6 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 1.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.6 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 1.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 2.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 11.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.6 | 4.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 0.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 6.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 2.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 1.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 1.9 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.6 | 4.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 9.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 3.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 3.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.6 | 0.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.6 | 2.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 1.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 1.8 | GO:0046909 | intermembrane transport(GO:0046909) |
0.6 | 3.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.6 | 3.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 2.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.6 | 2.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.6 | 2.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.6 | 1.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.6 | 1.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.6 | 8.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.6 | 1.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 0.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 1.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 0.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 3.5 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.6 | 0.6 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.6 | 2.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.2 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.6 | 1.8 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.6 | 1.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.6 | 9.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.6 | 4.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.6 | 1.7 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.6 | 2.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 2.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.6 | 2.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.6 | 1.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 7.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.6 | 1.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 8.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.6 | 6.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.6 | 1.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.6 | 10.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.6 | 0.6 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.6 | 1.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 5.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 1.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 0.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.6 | 1.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 4.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 5.6 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.6 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 2.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.6 | 2.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 2.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.6 | 3.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.6 | 8.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 2.2 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.6 | 2.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 0.6 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.6 | 1.7 | GO:0015867 | ATP transport(GO:0015867) |
0.6 | 1.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 0.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.6 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 0.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.5 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.5 | 4.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.5 | 2.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 4.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 1.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.5 | 1.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 1.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 4.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.5 | 1.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 2.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.5 | 7.6 | GO:0019915 | lipid storage(GO:0019915) |
0.5 | 2.7 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.5 | 37.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 3.8 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.5 | 0.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.5 | 1.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
0.5 | 4.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.5 | 2.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.5 | 0.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.5 | 0.5 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.5 | 1.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.5 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 2.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.5 | 1.6 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.5 | 1.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 4.8 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.5 | 1.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.5 | 1.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.5 | 2.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.5 | 0.5 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.5 | 1.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 2.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.5 | 6.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 5.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 4.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.5 | 0.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 0.5 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 3.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.5 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.5 | 1.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.5 | 3.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.5 | 0.5 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.5 | 1.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 0.5 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.5 | 4.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.5 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 4.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.5 | 2.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 1.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 1.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 2.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 5.6 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 1.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.5 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 2.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 4.0 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 1.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 4.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.5 | 1.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 2.0 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.5 | 2.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.5 | 2.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 1.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 1.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 3.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 1.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.5 | 2.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.5 | 6.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.5 | 2.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 11.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 1.0 | GO:0006833 | water transport(GO:0006833) |
0.5 | 4.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.5 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 12.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 7.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 2.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 0.5 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.5 | 5.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 1.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 1.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 4.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.5 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 2.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 15.3 | GO:0006956 | complement activation(GO:0006956) |
0.5 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.9 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 0.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.5 | 1.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.5 | 1.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 2.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.5 | 6.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.5 | 9.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 5.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 4.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.5 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 1.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.5 | 1.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 1.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 1.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.5 | 1.4 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.5 | 0.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 1.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.5 | 0.5 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.5 | 4.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.5 | 2.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.5 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 10.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 1.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 0.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 0.5 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.5 | 1.8 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
0.5 | 1.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.5 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 0.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.5 | 1.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.5 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 0.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 2.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.5 | 0.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 2.7 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 1.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.5 | 3.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 2.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.4 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 1.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.4 | GO:0035284 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 3.6 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.4 | 1.3 | GO:0009838 | abscission(GO:0009838) |
0.4 | 1.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 0.9 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.4 | 2.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 3.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 0.9 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.4 | 4.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 1.3 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 0.9 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.4 | 10.1 | GO:0030168 | platelet activation(GO:0030168) |
0.4 | 4.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.4 | 0.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 2.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 1.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.4 | 0.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 3.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 5.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 0.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 2.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 5.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.4 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.4 | 0.9 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 2.1 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.4 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.4 | 6.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 1.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.4 | 5.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 2.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 4.2 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.4 | 0.4 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.4 | 0.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 5.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.4 | 1.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 1.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 1.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 2.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 0.4 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 0.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 1.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.4 | 1.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 5.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 15.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 1.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 | 1.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 1.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.4 | 1.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 2.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 1.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.4 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 3.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 3.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 2.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 1.6 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.4 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 2.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 3.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 0.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.4 | 1.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.4 | 6.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 3.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 1.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 2.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 2.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 2.7 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 2.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.4 | 1.9 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 2.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.4 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.4 | 8.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.4 | 2.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.4 | 10.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.2 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 0.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.4 | 1.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.4 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.4 | 0.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.4 | 2.3 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.4 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 6.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 3.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 0.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 2.3 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.4 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.4 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 1.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.4 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.4 | 2.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 1.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.4 | 1.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.4 | 16.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 2.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 1.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 2.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.4 | 0.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 0.7 | GO:1990182 | exosomal secretion(GO:1990182) |
0.4 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 1.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 2.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 0.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 0.7 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 4.3 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.4 | 4.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 0.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 0.7 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.4 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.7 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.4 | 1.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 8.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 0.4 | GO:0042044 | fluid transport(GO:0042044) |
0.4 | 5.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.4 | 0.4 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.4 | 0.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 1.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 1.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 2.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.3 | 0.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.3 | 1.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.7 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 0.7 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.3 | 0.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.3 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.3 | 0.3 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 1.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.3 | 0.3 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.3 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 2.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 1.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.3 | 1.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 16.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 0.7 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.7 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.3 | 0.7 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.3 | 1.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 2.7 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.3 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.3 | 12.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.3 | 0.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.7 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.3 | 1.0 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.3 | 3.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.3 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 0.3 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.3 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 4.6 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.3 | 0.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.3 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 3.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.3 | 2.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.6 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 2.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 2.3 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 0.3 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
0.3 | 3.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 0.3 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.3 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 1.9 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) mitotic DNA replication(GO:1902969) |
0.3 | 0.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 1.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 3.4 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 2.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 13.1 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.3 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 2.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.3 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 1.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 1.5 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.3 | 0.6 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.3 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 6.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.9 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.3 | 3.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.3 | 0.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 0.6 | GO:1902414 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
0.3 | 2.4 | GO:0051904 | pigment granule transport(GO:0051904) |
0.3 | 0.3 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.3 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 20.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 8.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 1.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 2.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.3 | 1.8 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 1.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.6 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.3 | 0.3 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.3 | 0.3 | GO:0046015 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) regulation of transcription by glucose(GO:0046015) |
0.3 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 17.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 0.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 1.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 4.0 | GO:0001824 | blastocyst development(GO:0001824) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.3 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 1.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 4.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.3 | 1.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 1.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 1.4 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.3 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.3 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.3 | 0.6 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 5.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.3 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 1.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.3 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.3 | 0.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 11.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 2.8 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.3 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.1 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.3 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.3 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.3 | 0.5 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 4.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.8 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 2.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.8 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 1.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 16.4 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 1.9 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 1.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 0.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 5.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 1.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.3 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.3 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.5 | GO:0019081 | viral translation(GO:0019081) |
0.3 | 1.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 2.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.5 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.3 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.3 | 1.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 6.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.3 | 0.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.3 | 1.5 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 0.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.3 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.3 | 1.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.5 | GO:0032633 | interleukin-4 production(GO:0032633) |
0.2 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.5 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 3.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 5.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.2 | 2.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.0 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 1.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.2 | 1.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.2 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 1.2 | GO:0014075 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.2 | 3.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 1.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.5 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 1.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 1.2 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.2 | 5.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.2 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.2 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.2 | 0.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 0.7 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 1.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 1.4 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.2 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.9 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 4.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 0.5 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 12.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 2.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 4.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 1.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 3.5 | GO:0007129 | synapsis(GO:0007129) |
0.2 | 2.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 1.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.2 | 1.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 2.8 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.2 | 0.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 6.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 1.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.4 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 5.4 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.2 | 0.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 1.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.6 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.2 | 0.2 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.0 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.2 | 2.5 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.2 | 9.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.8 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 0.6 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 1.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 2.0 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 10.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 3.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 4.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.8 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 0.4 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 4.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.2 | GO:0009310 | amine catabolic process(GO:0009310) |
0.2 | 1.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.2 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.2 | 1.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.6 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 3.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.2 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 3.0 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 1.7 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
0.2 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 1.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.6 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.2 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.9 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.2 | 1.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 1.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 4.3 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 1.4 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.2 | 3.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 3.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 3.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 1.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 2.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.3 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.7 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.2 | 0.3 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.3 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.2 | 1.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:2000848 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 0.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 0.2 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.2 | 0.5 | GO:0051875 | pigment granule localization(GO:0051875) |
0.2 | 3.1 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 1.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 3.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 6.5 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.3 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.2 | 0.8 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 8.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 3.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 1.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 1.0 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 0.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 3.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 2.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.5 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.5 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 3.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.7 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 2.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.8 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.3 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 3.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 1.4 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 1.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.6 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.9 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.4 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.1 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 1.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:2000870 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
0.1 | 2.2 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 1.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.8 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.5 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 1.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 3.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 1.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 3.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.9 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 1.0 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.4 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.2 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 0.7 | GO:0060840 | artery development(GO:0060840) |
0.1 | 0.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 6.1 | GO:0043200 | response to amino acid(GO:0043200) |
0.1 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 17.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 6.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 7.7 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.3 | GO:0098659 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 0.0 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.0 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 6.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 1.0 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.0 | 1.3 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 34.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 1.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0038161 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.0 | 0.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.0 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 25.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.8 | 14.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.8 | 8.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.6 | 10.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.6 | 2.6 | GO:0031512 | motile primary cilium(GO:0031512) |
2.6 | 15.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
2.6 | 2.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.5 | 7.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.5 | 17.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.4 | 7.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.4 | 9.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.3 | 15.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.3 | 9.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.2 | 13.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.2 | 6.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.2 | 10.9 | GO:0030870 | Mre11 complex(GO:0030870) |
2.2 | 6.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.1 | 12.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.1 | 10.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.1 | 6.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.0 | 6.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.0 | 5.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.9 | 7.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.9 | 7.4 | GO:0030478 | actin cap(GO:0030478) |
1.8 | 12.9 | GO:0042627 | chylomicron(GO:0042627) |
1.8 | 5.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.7 | 5.2 | GO:0044393 | microspike(GO:0044393) |
1.7 | 5.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.7 | 1.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
1.6 | 4.9 | GO:0097413 | Lewy body(GO:0097413) |
1.6 | 3.2 | GO:0031430 | M band(GO:0031430) |
1.6 | 8.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.6 | 12.9 | GO:0045179 | apical cortex(GO:0045179) |
1.6 | 9.4 | GO:0000796 | condensin complex(GO:0000796) |
1.6 | 6.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.5 | 4.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.5 | 4.6 | GO:0097443 | sorting endosome(GO:0097443) |
1.5 | 5.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.4 | 14.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.4 | 2.9 | GO:0042585 | germinal vesicle(GO:0042585) |
1.4 | 8.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.4 | 19.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.4 | 5.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.4 | 2.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.4 | 2.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 5.5 | GO:0038201 | TOR complex(GO:0038201) |
1.4 | 4.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.3 | 5.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 3.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.3 | 13.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.3 | 9.1 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.2 | 8.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.2 | 2.5 | GO:0043218 | compact myelin(GO:0043218) |
1.2 | 8.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.2 | 3.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.2 | 3.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.2 | 2.4 | GO:0031672 | A band(GO:0031672) |
1.2 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 6.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.2 | 3.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.2 | 4.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.1 | 5.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 13.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.1 | 5.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 5.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.1 | 1.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.1 | 4.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 4.4 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 4.4 | GO:0071203 | WASH complex(GO:0071203) |
1.1 | 65.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.1 | 3.3 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 3.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.1 | 8.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.1 | 4.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.1 | 7.4 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.1 | 3.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 10.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 5.2 | GO:0033503 | HULC complex(GO:0033503) |
1.0 | 4.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 3.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.0 | 4.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 2.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.0 | 3.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 7.1 | GO:0032797 | SMN complex(GO:0032797) |
1.0 | 7.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 11.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 7.0 | GO:0031931 | TORC1 complex(GO:0031931) |
1.0 | 5.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.0 | 4.9 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 6.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 4.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 4.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 1.0 | GO:1903349 | omegasome membrane(GO:1903349) |
1.0 | 8.6 | GO:0005869 | dynactin complex(GO:0005869) |
1.0 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 2.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 5.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.9 | 5.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 1.9 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 3.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 2.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 12.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 40.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.9 | 0.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.9 | 0.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 4.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.9 | 7.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 4.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 34.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.8 | 9.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 2.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 4.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.8 | 7.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.8 | 7.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.8 | 12.6 | GO:0002102 | podosome(GO:0002102) |
0.8 | 5.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 3.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.8 | 3.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.8 | 4.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 7.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 18.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.8 | 2.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.8 | 5.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 3.2 | GO:0033267 | axon part(GO:0033267) |
0.8 | 5.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.8 | 26.5 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 2.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.8 | 4.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 2.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 2.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.8 | 4.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.8 | 2.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 1.6 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.8 | 8.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.8 | 3.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.8 | 6.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 2.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 13.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.8 | 31.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.8 | 3.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 3.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 6.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 32.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 1.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 3.7 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 3.0 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 10.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 5.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 23.3 | GO:0012505 | endomembrane system(GO:0012505) |
0.7 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 5.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 2.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 22.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 1.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 15.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.7 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 60.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 3.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 4.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 7.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.7 | 8.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.7 | 4.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 0.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.7 | 33.4 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 19.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.7 | 2.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 6.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 10.5 | GO:0030904 | retromer complex(GO:0030904) |
0.7 | 8.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.7 | 28.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 5.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 8.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 9.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 4.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 3.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 7.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 1.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 2.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 7.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 11.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 3.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 3.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 3.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 9.5 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 8.8 | GO:0045120 | pronucleus(GO:0045120) |
0.6 | 3.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.6 | 11.3 | GO:0005769 | early endosome(GO:0005769) |
0.6 | 55.7 | GO:0030496 | midbody(GO:0030496) |
0.6 | 8.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 6.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 1.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 3.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 1.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 7.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.6 | 8.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 5.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 9.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 8.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 4.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 2.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 1.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.6 | 2.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 7.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.6 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 4.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 5.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 8.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.6 | 1.7 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.6 | 27.5 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 7.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 4.9 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 2.2 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
0.5 | 8.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 39.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 5.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 7.0 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 1.6 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 1.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.5 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 10.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 5.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 79.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.5 | 3.2 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 23.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.5 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 3.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 2.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 46.7 | GO:0001726 | ruffle(GO:0001726) |
0.5 | 61.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.5 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 6.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 13.3 | GO:0005903 | brush border(GO:0005903) |
0.5 | 5.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 3.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 67.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.5 | 2.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 2.4 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 2.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 3.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 9.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 162.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 3.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 11.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 1.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 13.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.5 | 4.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 46.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.5 | 6.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 12.7 | GO:0097517 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
0.5 | 0.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 16.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.5 | 22.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 1.9 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 9.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 2.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 1.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 9.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 0.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 1.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 9.5 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 4.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 17.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 20.9 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.4 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 3.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 7.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 3.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 35.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 3.1 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 21.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.4 | 5.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 9.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 2.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 23.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.4 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 3.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 370.9 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 5.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 2.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 6.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 3.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 1.4 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.4 | 460.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 2.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 17.4 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 0.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 2.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 3.5 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 16.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 2.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 7.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 0.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.7 | GO:0002177 | manchette(GO:0002177) |
0.3 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 0.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.3 | 14.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 6.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 44.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 3.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 0.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.6 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.3 | 1.7 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 1.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 0.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 3.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 3.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 1.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 0.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.3 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 18.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.3 | 45.8 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 194.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 8.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 2.0 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.3 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 139.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 59.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 174.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 0.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 3.1 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 3.5 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 2.2 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 3.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 35.1 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 2.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 9.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 2.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 0.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 2.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.9 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 5.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.6 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 11.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.7 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 35.1 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 9.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.3 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 84.0 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 23.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 3.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 100.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.0 | GO:0000922 | spindle pole(GO:0000922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 36.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
8.2 | 24.5 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
6.3 | 25.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
4.7 | 14.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
4.5 | 13.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
4.0 | 12.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
4.0 | 12.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
3.8 | 15.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.5 | 10.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.3 | 9.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.2 | 9.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
3.2 | 22.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.9 | 8.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 8.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.8 | 8.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.8 | 8.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.7 | 8.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
2.7 | 18.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.7 | 8.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.6 | 5.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.6 | 15.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.5 | 10.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.5 | 20.0 | GO:0008430 | selenium binding(GO:0008430) |
2.5 | 2.5 | GO:0035276 | ethanol binding(GO:0035276) |
2.5 | 19.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
2.4 | 9.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.4 | 4.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.4 | 4.8 | GO:0070538 | oleic acid binding(GO:0070538) |
2.4 | 7.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.3 | 23.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.3 | 7.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.2 | 8.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.1 | 10.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.1 | 8.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.1 | 4.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
2.1 | 8.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.0 | 18.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.0 | 8.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
2.0 | 4.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.0 | 5.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.0 | 5.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.0 | 7.8 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
1.9 | 11.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.9 | 1.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.9 | 15.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.9 | 5.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.9 | 9.3 | GO:0070061 | fructose binding(GO:0070061) |
1.8 | 5.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.8 | 27.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.8 | 7.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.8 | 7.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.8 | 25.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.7 | 7.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.7 | 6.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.7 | 6.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.7 | 5.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.7 | 5.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.6 | 13.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.6 | 6.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.6 | 4.8 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.6 | 11.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.6 | 4.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.6 | 4.7 | GO:0000339 | RNA cap binding(GO:0000339) |
1.6 | 4.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.6 | 9.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.6 | 3.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.5 | 6.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.5 | 3.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.5 | 18.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.5 | 6.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.5 | 4.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.5 | 5.9 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
1.5 | 26.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.5 | 5.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.5 | 8.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.5 | 5.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.5 | 13.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.5 | 8.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.5 | 4.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 1.4 | GO:0089720 | caspase binding(GO:0089720) |
1.4 | 8.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.4 | 17.3 | GO:0031005 | filamin binding(GO:0031005) |
1.4 | 5.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.4 | 9.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.4 | 4.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.4 | 4.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.3 | 13.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.3 | 1.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 5.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 2.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.3 | 9.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.3 | 5.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.3 | 2.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.3 | 5.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.3 | 5.2 | GO:0045340 | mercury ion binding(GO:0045340) |
1.3 | 6.5 | GO:0002054 | nucleobase binding(GO:0002054) |
1.3 | 3.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.3 | 3.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.3 | 1.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.3 | 1.3 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
1.3 | 5.1 | GO:0043515 | kinetochore binding(GO:0043515) |
1.3 | 2.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.3 | 2.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.3 | 16.3 | GO:0043274 | phospholipase binding(GO:0043274) |
1.3 | 5.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.2 | 3.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.2 | 3.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.2 | 7.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.2 | 7.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.2 | 6.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.2 | 13.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.2 | 14.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 3.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.2 | 7.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.2 | 7.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.2 | 4.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 16.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.2 | 2.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.2 | 7.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.2 | 8.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.2 | 4.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.2 | 1.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.2 | 2.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.2 | 3.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.1 | 9.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.1 | 9.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.1 | 1.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 8.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 6.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 4.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.1 | 2.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 10.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.1 | 24.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 38.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.1 | 5.5 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.1 | 8.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.1 | 8.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 6.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.1 | 3.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.1 | 2.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.1 | 12.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.1 | 6.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.1 | 3.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.1 | 4.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.1 | 3.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 6.6 | GO:0008199 | ferric iron binding(GO:0008199) |
1.1 | 3.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.1 | 7.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 1.1 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 9.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 14.1 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 7.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.1 | 16.2 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 3.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.1 | 5.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.1 | 1.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.0 | 8.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 11.5 | GO:0044548 | S100 protein binding(GO:0044548) |
1.0 | 6.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.0 | 4.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 16.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.0 | 3.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.0 | 19.6 | GO:0001848 | complement binding(GO:0001848) |
1.0 | 4.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 32.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.0 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 10.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.0 | 3.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.0 | 3.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.0 | 5.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 5.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.0 | 3.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 3.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 8.9 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 1.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.0 | 3.0 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 20.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.0 | 4.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 2.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 1.0 | GO:0032190 | acrosin binding(GO:0032190) |
1.0 | 4.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 7.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.0 | 26.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.0 | 10.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 2.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 5.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.9 | 15.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.9 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 24.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.9 | 4.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 9.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.9 | 5.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 4.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.9 | 7.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.9 | 4.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.9 | 6.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 3.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 2.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.9 | 13.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.9 | 3.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 11.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.9 | 3.6 | GO:0043531 | ADP binding(GO:0043531) |
0.9 | 3.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.9 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 5.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.9 | 5.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.9 | 9.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 9.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.9 | 28.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.9 | 10.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.9 | 25.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.9 | 4.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 4.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.9 | 2.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.9 | 2.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 9.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 2.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.9 | 6.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.9 | 7.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 3.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.9 | 14.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.9 | 0.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.8 | 1.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.8 | 4.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 11.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.8 | 1.7 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.8 | 5.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 10.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.8 | 4.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.8 | 2.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.8 | 3.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 5.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 2.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.8 | 2.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 14.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 5.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 2.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.8 | 4.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 8.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.8 | 2.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.8 | 7.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.8 | 13.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 15.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.8 | 2.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.8 | 5.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.8 | 7.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 4.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 8.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 12.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.8 | 10.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.8 | 3.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.8 | 5.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 2.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.8 | 1.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.8 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 13.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 4.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 6.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.8 | 3.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 3.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.8 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 6.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.8 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 2.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 3.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.8 | 3.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 5.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 4.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.8 | 3.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.8 | 1.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 3.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 4.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.8 | 1.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.8 | 3.8 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.8 | 3.0 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 4.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.8 | 2.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.7 | 16.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.7 | 3.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 1.5 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 7.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 28.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 2.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 3.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.7 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.7 | 18.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 2.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 2.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 2.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 3.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.7 | 2.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 9.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 1.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 2.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.7 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.7 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 1.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.7 | 3.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 12.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 9.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 2.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 20.9 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.7 | 2.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 11.8 | GO:0071949 | FAD binding(GO:0071949) |
0.7 | 3.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.7 | 5.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 8.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 17.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.7 | 4.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.7 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 6.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 2.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 2.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 6.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.7 | 2.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 16.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.7 | 4.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 5.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.7 | 5.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.7 | 3.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 2.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 10.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 2.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.7 | 10.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 49.9 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 4.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 57.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 1.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 2.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 12.0 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 4.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.6 | 1.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 3.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 16.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 2.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 20.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.6 | 1.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 5.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 8.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.6 | 5.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 4.3 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 6.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.6 | 3.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 4.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.6 | 5.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.6 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 3.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.6 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 16.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.6 | 3.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.6 | 3.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.6 | 3.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 2.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 1.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 6.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 6.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 32.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.6 | 1.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 1.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 23.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 9.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 1.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 2.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 1.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 2.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.6 | 2.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.6 | 4.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.6 | 1.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.6 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 3.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 4.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 4.0 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 1.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 63.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 7.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 2.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 14.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 1.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 2.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 1.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 2.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 1.7 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 1.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.5 | 20.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 1.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 8.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 2.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.5 | 2.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.5 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 2.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 1.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 2.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.5 | 1.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 2.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 6.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 4.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.5 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 1.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 3.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 12.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 2.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 2.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 29.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.5 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 1.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 2.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) D-lysine oxidase activity(GO:0043912) |
0.5 | 3.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 5.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 2.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.5 | 2.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 3.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.5 | 1.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 7.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 1.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 89.0 | GO:0070738 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.5 | 10.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 1.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 4.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 2.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.5 | 1.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.5 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.5 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 4.8 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 6.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 1.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 4.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 1.9 | GO:0042887 | urea transmembrane transporter activity(GO:0015204) amide transmembrane transporter activity(GO:0042887) |
0.5 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 1.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 2.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.5 | 0.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.5 | 2.3 | GO:0001135 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 28.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.5 | 0.9 | GO:0016894 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.5 | 8.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 15.9 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 13.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 2.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 6.8 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 3.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 2.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 12.7 | GO:0080030 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.4 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 7.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 4.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.4 | 6.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 2.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 4.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 5.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 3.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 1.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.4 | 1.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 14.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 29.9 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 6.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 32.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 0.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.4 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 3.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 21.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 0.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 5.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 3.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 2.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 3.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 4.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 4.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 0.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 0.4 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.4 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 1.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 0.8 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.4 | 2.3 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.4 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 6.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 9.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.4 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 7.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 7.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 10.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 1.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 7.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 6.1 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 2.8 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.4 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 2.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 45.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.3 | 1.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 18.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 1.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 1.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 3.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 12.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 0.7 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.3 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 2.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 3.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 9.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 0.3 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.3 | 1.7 | GO:0050661 | NADP binding(GO:0050661) |
0.3 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 44.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 2.9 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 3.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 2.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.3 | 25.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 3.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 3.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 0.3 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutLalpha complex binding(GO:0032405) MutSalpha complex binding(GO:0032407) |
0.3 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 17.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 1.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 9.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 5.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 2.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.3 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 3.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 0.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 7.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 0.6 | GO:0050542 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.3 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 11.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 2.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 12.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 3.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 5.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 19.4 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 2.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 2.8 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.3 | 6.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 6.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 7.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 3.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 8.1 | GO:0042562 | hormone binding(GO:0042562) |
0.3 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 8.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 15.0 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 5.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 5.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 4.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 0.3 | GO:0001025 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III transcription factor binding(GO:0001025) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 1.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.8 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.3 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 1.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 1.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 4.3 | GO:0019842 | vitamin binding(GO:0019842) |
0.3 | 2.0 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.3 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 1.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 1.5 | GO:0008409 | 5'-3' exoribonuclease activity(GO:0004534) 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 16.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 11.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 2.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 8.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 4.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 3.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 14.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.5 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.5 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.2 | 7.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 2.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 90.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 0.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.2 | 8.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.8 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 11.6 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 10.1 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 7.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 4.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 6.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 29.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 27.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.5 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.2 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 3.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 1.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.3 | GO:0034790 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 13.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 1.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.2 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 5.6 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.2 | 0.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 3.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 12.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 32.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 7.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.6 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 3.3 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 23.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.3 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 8.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 2.2 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 8.9 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 3.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 45.4 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 7.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 2.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.8 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.6 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 41.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 3.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.7 | 72.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.4 | 45.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.3 | 43.6 | PID ARF6 PATHWAY | Arf6 signaling events |
1.3 | 7.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 3.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.3 | 40.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.3 | 21.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.3 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.1 | 36.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 27.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.1 | 27.7 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 16.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 10.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 37.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 31.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.0 | 2.0 | ST STAT3 PATHWAY | STAT3 Pathway |
1.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.0 | 22.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.0 | 27.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.9 | 10.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 7.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 21.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.9 | 21.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 4.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 9.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 24.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.8 | 8.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.8 | 6.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 8.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 8.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 5.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.8 | 7.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 14.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.8 | 17.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 9.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 31.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 5.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 21.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.7 | 40.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 6.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 25.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 8.7 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 7.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 3.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 7.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 26.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 12.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 4.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 23.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 12.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.6 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 35.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 10.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 16.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 14.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 10.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 8.2 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 11.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 11.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 11.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 10.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 22.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 6.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 8.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 5.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 5.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 11.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 6.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 5.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 5.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 28.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.5 | 3.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 4.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 10.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 8.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 3.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 5.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 2.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 2.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 3.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 3.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 2.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 9.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 1.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 1.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 9.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 7.8 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 1.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 5.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 4.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 4.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 9.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 41.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 3.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 4.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 3.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 3.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 5.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 20.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 18.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 4.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.9 | 29.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.8 | 2.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
2.5 | 2.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.9 | 1.9 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
1.9 | 3.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.8 | 3.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.7 | 25.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.7 | 3.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 22.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.6 | 16.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.6 | 16.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.6 | 20.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.5 | 38.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.5 | 12.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.5 | 27.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.5 | 4.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.4 | 31.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.4 | 1.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.4 | 12.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.4 | 2.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.4 | 4.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.4 | 2.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.4 | 1.4 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
1.3 | 16.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 12.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 7.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.2 | 6.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.2 | 8.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.2 | 32.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.2 | 20.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.2 | 16.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.2 | 14.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.2 | 34.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.2 | 6.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.1 | 16.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.1 | 26.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.1 | 27.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 28.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 16.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.1 | 11.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.1 | 41.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.1 | 6.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 12.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.0 | 10.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.0 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.0 | 11.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.0 | 9.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.0 | 2.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
1.0 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.0 | 13.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 14.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 1.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.9 | 2.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 14.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 8.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 28.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.9 | 9.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 9.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.9 | 11.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.9 | 12.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 6.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.9 | 9.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 12.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.9 | 42.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.8 | 2.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.8 | 56.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.8 | 26.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.8 | 9.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 13.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 11.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.8 | 10.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.8 | 5.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 4.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.8 | 3.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.8 | 3.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 7.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 8.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 12.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 10.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 14.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 4.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 10.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.7 | 31.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.7 | 1.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.7 | 2.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.7 | 3.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 3.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.7 | 21.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.7 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 4.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.7 | 4.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 8.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 29.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.7 | 9.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.7 | 1.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 4.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.7 | 9.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 10.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.6 | 5.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 6.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 1.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.6 | 10.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 8.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 11.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 6.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 5.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 32.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 22.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.6 | 4.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.6 | 14.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 3.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.6 | 14.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 4.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.6 | 4.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 19.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 8.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 6.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 19.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 10.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.5 | 14.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 6.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 6.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 4.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 4.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 8.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 9.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 6.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 36.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 3.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 2.0 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.5 | 2.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 10.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 20.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 8.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 2.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 5.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 3.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 4.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 6.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 58.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 21.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 6.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 3.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 8.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.5 | 1.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 9.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 2.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 3.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 24.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 9.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 3.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 14.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 2.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 7.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.4 | 2.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 7.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 20.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 0.8 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.4 | 3.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 7.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 12.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 42.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 2.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 8.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 6.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.4 | 1.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 4.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 6.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 13.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 5.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 4.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 7.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 28.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 4.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 8.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 0.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 4.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 2.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 2.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 5.4 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.3 | 2.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 0.5 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.3 | 13.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 18.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 2.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 4.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 19.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 21.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 4.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 6.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 0.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.2 | 2.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 4.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 3.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 6.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.9 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.1 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 3.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |